MD HB1026 | 2012 | Regular Session
Status
Spectrum: Moderate Partisan Bill (Democrat 28-7)
Status: Introduced on February 10 2012 - 25% progression, died in committee
Action: 2012-02-22 - Hearing 3/20 at 1:00 p.m.
Pending: House Health and Government Operations Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 10 2012 - 25% progression, died in committee
Action: 2012-02-22 - Hearing 3/20 at 1:00 p.m.
Pending: House Health and Government Operations Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Establishing the Sickle Cell Disease Research Program to be administered by the Maryland Technology Development Corporation to provide grants for specified sickle cell disease research projects; establishing the purposes of the Program; establishing specified types of grants to be awarded under the Program; establishing the Sickle Cell Disease Research Fund; providing for the purposes and composition of the Fund; etc.
Title
Economic Development - Sickle Cell Disease Research Program
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2012-02-22 | Hearing 3/20 at 1:00 p.m. | |
| 2012-02-10 | First Reading Health and Government Operations |
Subjects
Appropriations
Commerce and Business
Diseases
Grants
Industry and Technology
Loans
Medical Research
Public Corporations and Instrumentalities
Reports
Revenue and Taxes
Rules and Regulations
Commerce and Business
Diseases
Grants
Industry and Technology
Loans
Medical Research
Public Corporations and Instrumentalities
Reports
Revenue and Taxes
Rules and Regulations
Maryland State Sources
| Type | Source |
|---|---|
| Summary | https://mgaleg.maryland.gov/mgawebsite/Search/Legislation?target=/2012rs/billfile/HB1026.htm |
| Text | http://mlis.state.md.us/2012rs/bills/hb/hb1026f.pdf |
